We are live on
!
Find out more
WP
Woodline Partners Portfolio holdings
AUM
$26.4B
1-Year Est. Return
44.85%
This Fund
S&P 500
This Quarter
Est. Return
-5.17%
1 Year Est. Return
+44.85%
3 Year Est. Return
+131.23%
5 Year Est. Return
+174.12%
10 Year Est. Return
–
AUM
$6.16B
AUM Growth
-$821M
(-12%)
Cap. Flow
-$392M
Cap. Flow
% of AUM
-6.36%
Top 10 Holdings %
Top 10 Hldgs %
16.27%
Holding
911
New
217
Increased
113
Reduced
100
Closed
202
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
SGEN
Seagen Inc. Common Stock
SGEN
|
+$100M |
| 2 |
ZNGA
ZYNGA INC. CL A COMMON
ZNGA
|
+$97M |
| 3 |
Lam Research
LRCX
|
+$85.4M |
| 4 |
Boston Scientific
BSX
|
+$79.4M |
| 5 |
Merck
MRK
|
+$67M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AbbVie
ABBV
|
+$145M |
| 2 |
ASML
ASML
|
+$119M |
| 3 |
Qorvo
QRVO
|
+$89M |
| 4 |
Microsoft
MSFT
|
+$82.9M |
| 5 |
Intuitive Surgical
ISRG
|
+$75.5M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 38.56% |
| 2 | Technology | 29.01% |
| 3 | Industrials | 8.79% |
| 4 | Communication Services | 5.99% |
| 5 | Financials | 5.91% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
26
Vishay Intertechnology
VSH
$5.32B
| $43.4M | 0.7% |
2,215,651
-758,154
| -25% | -$15.3M |
|
27
Legend Biotech
LEGN
$3.67B
| $42.6M | 0.69% |
1,171,051
-307,615
| -21% | -$12.2M |
|
28
Baxter International
BAX
$14.5B
| $42.4M | 0.69% |
546,345
+29,894
| +6% | +$2.5M |
|
29
Qualcomm
QCOM
$156B
| $41.1M | 0.67% |
+268,660
| New | +$45.1M |
|
|
HZNP
30
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
| $40.3M | 0.65% |
383,288
-499,815
| -57% | -$48.7M |
|
31
Fortive
FTV
$18B
| $40.2M | 0.65% |
875,386
+703,455
| +409% | +$34.8M |
|
32
Agilent Technologies
A
$39.3B
| $40.2M | 0.65% |
303,658
+136,915
| +82% | +$18.8M |
|
33
Amgen
AMGN
$203B
| $39.9M | 0.65% |
165,187
+75,083
| +83% | +$17.3M |
|
34
McKesson
MCK
$99.4B
| $39.8M | 0.65% |
129,982
+52,293
| +67% | +$14.2M |
|
35
Johnson Controls International
JCI
$88.5B
| $38.8M | 0.63% |
592,255
+350,022
| +144% | +$24.1M |
|
36
General Dynamics
GD
$104B
| $37.9M | 0.62% |
+157,326
| New | +$34.9M |
|
|
37
Qorvo
QRVO
$7.83B
| $37.9M | 0.61% |
305,247
-657,963
| -68% | -$89M |
|
38
Zimmer Biomet
ZBH
$18.6B
| $36.7M | 0.6% |
286,685
+162,894
| +132% | +$19.6M |
|
|
NATI
39
DELISTED
National Instruments Corp
NATI
| $36M | 0.58% |
887,196
-671,572
| -43% | -$27.1M |
|
40
STMicroelectronics
STM
$46.2B
| $35.8M | 0.58% |
+829,415
| New | +$36.7M |
|
41
Nutanix
NTNX
$16.5B
| $35.7M | 0.58% |
1,331,978
-146,026
| -10% | -$3.91M |
|
42
Eli Lilly
LLY
$994B
| $35M | 0.57% |
122,335
-264,966
| -68% | -$68.2M |
|
43
Humana
HUM
$44.3B
| $34.9M | 0.57% |
80,134
+52,825
| +193% | +$22.1M |
|
44
Alkermes
ALKS
$8.42B
| $34.6M | 0.56% |
1,314,406
-304,399
| -19% | -$7.54M |
|
45
On Holding
ONON
$12.6B
| $34.1M | 0.55% |
+1,349,629
| New | +$36M |
|
46
Centene
CNC
$31.1B
| $33.9M | 0.55% |
402,214
+197,708
| +97% | +$16.2M |
|
|
ESMT
47
DELISTED
EngageSmart, Inc.
ESMT
| $33.7M | 0.55% |
1,580,286
+690,254
| +78% | +$14.3M |
|
48
Edwards Lifesciences
EW
$51B
| $33.4M | 0.54% |
+283,730
| New | +$31.8M |
|
|
SPR
49
DELISTED
Spirit AeroSystems
SPR
| $32.6M | 0.53% |
667,064
+208,560
| +45% | +$9.75M |
|
50
Pfizer
PFE
$142B
| $32.5M | 0.53% |
626,853
-362,770
| -37% | -$18.8M |
|
Similar funds
PAM
TCIIS
UIM
Woodline Partners's Q1 2022 Portfolio in Review
As of Q1 2022, Woodline Partners held 911 positions worth $6.16B, down 12% from $6.98B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
Woodline Partners withdrew a net $392M in Q1 2022, closing 202 positions and reducing 100 holdings. Its most notable exit was AbbVie, an estimated $145M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 39% of assets, down from 41% a quarter earlier, followed by Technology and Industrials.
Against the trend, Woodline Partners opened a new position in ZYNGA INC. CL A COMMON worth $102M.
- Woodline Partners's largest Q1 2022 buy was ZYNGA INC. CL A COMMON: 11,039,458 shares worth $102M.
- Woodline Partners added most to Seagen Inc. Common Stock in Q1 2022, an estimated $100M increase.
- Woodline Partners's biggest Q1 2022 reduction was Qorvo, cutting an estimated $89M.
- Woodline Partners fully exited AbbVie in Q1 2022, selling an estimated $145M.
- Woodline Partners's ten largest holdings make up 16% of its $6.16B portfolio in Q1 2022.
- Woodline Partners opened 217 new positions and closed 202 in Q1 2022.
- Woodline Partners's portfolio value fell 12% quarter-over-quarter to $6.16B.
Based on Woodline Partners's 13F filing for Q1 2022, filed 16 May 2022.